A unique clinical feature of Takotsubo syndrome (TTS) is the stress trigger factor. Different types of triggers exist, generally divided into emotional and physical stressor. The aim was to create long-term registry of all consecutive patients with TTS across all disciplines in our large university hospital. We enrolled patients on the basis of meeting the diagnostic criteria of the international InterTAK Registry. We aimed to determine type of triggers, clinical characteristics, and outcome of TTS patients during 10 years period. In our prospective, academic, single centre registry, we enrolled 155 consecutive patients with diagnoses of TTS between October 2013 and October 2022. The patients were divided into three groups, those having unknown (n = 32; 20.6%), emotional (n = 42; 27.1%), or physical (n = 81; 52.3%) triggers. Clinical characteristics, cardiac enzyme levels, echocardiographic findings, including ejection fraction, and TTS type did not differ among the groups. Chest pain was less common in the group of patients with a physical trigger. On the other hand, arrhythmogenic disorders such as prolonged QT intervals, cardiac arrest requiring defibrillation, and atrial fibrillation were more common among the TTS patients with unknown triggers compared with the other groups. The highest in-hospital mortality was observed between patients having physical trigger (16% vs. 3.1% in TTS with emotional trigger and 4.8% in TTS with unknown trigger; P = 0.060). Conclusion: More than half of the patients with TTS diagnosed in a large university hospital had a physical trigger as a stress factor. An essential part of caring for these types of patients is the correct identification of TTS in the context of severe other conditions and the absence of typical cardiac symptoms. Patients with physical trigger have a significantly higher risk of acute heart complications. Interdisciplinary cooperation is essential in the treatment of patients with this diagnosis.

3rd Faculty of Medicine Charles University Ruska 2411 Prague 100 00 Czechia

Cardiocentre of University Hospital Kralovske Vinohrady Srobarova 1150 50 Prague 100 34 Czechia

See more in PubMed

Sato H, Tateishi H, Uchida T, Dote K, Ishihara M, Kodama K et al. . Clinical aspect of myocardial injury: from ischemia to heart failure. Kagaku Hyoronsha 1990;2:55–64.

Redfors B, Vedad R, Angerås O, Råmunddal T, Petursson P, Haraldsson I et al. . Mortality in Takotsubo syndrome is similar to mortality in myocardial infarction—a report from the SWEDEHEART registry. Int J Cardiol 2015;185:282–289. PubMed

Ghadri JR, Kato K, Cammann VL, Gili S, Jurisic S, Di Vece D et al. . Long-term prognosis of patients with Takotsubo syndrome. J Am Coll Cardiol 2018;72:874–882. PubMed

Omerovic E, Citro R, Bossone E, Redfors B, Backs J, Bruns B et al. . Pathophysiology of Takotsubo syndrome—a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology—part 1: overview and the central role for catecholamines and sympathetic nervous system. Eur J Heart Fail 2022;24:257–273. PubMed

Ghadri JR, Cammann VL, Jurisic S, Seifert B, Napp LC, Diekmann J et al. . A novel clinical score (InterTAK diagnostic score) to differentiate Takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry. Eur J Heart Fail 2017;19:1036–1042. PubMed

Cammann VL, Scheitz JF, von Rennenberg R, Jäncke L, Nolte CH, Szawan KA et al. . Clinical correlates and prognostic impact of neurologic disorders in Takotsubo syndrome. Sci Rep 2021;11:23555. PubMed PMC

Kato K, Cammann VL, Napp LC, Szawan KA, Micek J, Dreiding S et al. . Prognostic impact of acute pulmonary triggers in patients with Takotsubo syndrome: new insights from the International Takotsubo Registry. ESC Heart Fail 2021;8:1924–1932. PubMed PMC

Lachmet-Thebaud L, Marchandot B, Matsushita K, Dagrenat C, Peillex M, Sato C et al. . Systemic inflammatory response syndrome is a major determinant of cardiovascular outcome in Takotsubo syndrome. Circ J 2020;84:592–600. PubMed

Singh S, Desai R, Gandhi Z, Fong HK, Doreswamy S, Desai V et al. . Takotsubo syndrome in patients with COVID-19: a systematic review of published cases. SN Compr Clin Med 2020;2:2102–2108. PubMed PMC

Dichtl W, Tuovinen N, Barbieri F, Adukauskaite A, Senoner T, Rubatscher A et al. . Functional neuroimaging in the acute phase of Takotsubo syndrome: volumetric and functional changes of the right insular cortex. Clin Res Cardiol 2020;109:1107–1113. PubMed PMC

Templin C, Hänggi J, Klein C, Topka MS, Hiestand T, Levinson RA et al. . Altered limbic and autonomic processing supports brain–heart axis in Takotsubo syndrome. Eur Heart J 2019;40:1183–1187. PubMed PMC

Ghadri J-R, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ et al. . International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J 2018;39:2032–2046. PubMed PMC

Zhang J, Liao Y, Cheng X, Chen J, Chen P, Gao X et al. . Myosin specific-T lymphocytes mediated myocardial inflammation in adoptive transferred rats. Cell Mol Immunol 2006;3:445–451. PubMed

Sattler S, Couch LS, Harding SE. Takotsubo syndrome: latest addition to the expanding family of immune-mediated diseases? JACC Basic Transl Sci 2018;3:779–781. PubMed PMC

Shao Y, Redfors B, Täng MS, Möllmann H, Troidl C, Szardien S et al. . Novel rat model reveals important roles of beta-adrenoreceptors in stress-induced cardiomyopathy. Int J Cardiol 2013;168:1943–1950. PubMed

Couch LS, Harding SE. Takotsubo syndrome: stress or NO stress? JACC Basic Transl Sci 2018;3:227–229. PubMed PMC

Munzel T, Templin C, Cammann VL, Hahad O.. Takotsubo syndrome: impact of endothelial dysfunction and oxidative stress. Free Radic Biol Med 2021;169:216–223. PubMed

Morgan BJ, Crabtree DC, Palta M, Skatrud JB.. Combined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans. J Appl Physiol 1995;79:205–213. PubMed

Surikow SY, Nguyen TH, Stafford I, Chapman M, Chacko S, Singh K et al. . Nitrosative stress as a modulator of inflammatory change in a model of Takotsubo syndrome. JACC Basic Transl Sci 2018;3:213–226. PubMed PMC

Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M et al. . Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med 2015;373:929–938. PubMed

Looi J-L, Verryt T, McLeod P, Chan C, Pemberton J, Webster M et al. . Type of stressor and medium-term outcomes after Takotsubo syndrome: what becomes of the broken hearted? (ANZACS-QI 59). Heart Lung Circ 2022;31:499–507. PubMed

Frangieh AH, Obeid S, Ghadri J-R, Imori Y, D'Ascenzo F, Kovac M et al. . ECG criteria to differentiate between Takotsubo (stress) cardiomyopathy and myocardial infarction. J Am Heart Assoc 2016;5:e003418. PubMed PMC

El-Battrawy I, Cammann VL, Kato K, Szawan KA, Di Vece D, Rossi A et al. . Impact of atrial fibrillation on outcome in Takotsubo syndrome: data from the International Takotsubo Registry. J Am Heart Assoc 2021;10:e014059. PubMed PMC

Stiermaier T, Santoro F, Eitel C, Graf T, Möller C, Tarantino N et al. . Prevalence and prognostic relevance of atrial fibrillation in patients with Takotsubo syndrome. Int J Cardiol 2017;245:156–161. PubMed

Jesel L, Berthon C, Messas N, Lim HS, Girardey M, Marzak H et al. . Atrial arrhythmias in Takotsubo cardiomyopathy: incidence, predictive factors, and prognosis. Europace 2019;21:298–305. PubMed

Ghadri J-R, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ et al. . International expert consensus document on Takotsubo syndrome (part II): diagnostic workup, outcome, and management. Eur Heart J 2018;39:2047–2062. PubMed PMC

Omerovic E, Citro R, Bossone E, Redfors B, Backs J, Bruns B et al. . Pathophysiology of Takotsubo syndrome—a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology—part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications. Eur J Heart Fail 2022;24:274–286. PubMed

El-Battrawy I, Zhao Z, Lan H, Schünemann J-D, Sattler K, Buljubasic F et al. . Estradiol protection against toxic effects of catecholamine on electrical properties in human-induced pluripotent stem cell derived cardiomyocytes. Int J Cardiol 2018;254:195–202. PubMed

El-Battrawy I, Lang S, Ansari U, Tülümen E, Schramm K, Fastner C et al. . Prevalence of malignant arrhythmia and sudden cardiac death in Takotsubo syndrome and its management. Europace 2018;20:843–850. PubMed

Brown KH, Trohman RG, Madias C. Arrhythmias in Takotsubo cardiomyopathy. Card Electrophysiol Clin 2015;7:331–340. PubMed